STEM BIO
Stem Bio is a developer of stem cell therapy and anti-cancer drugs.
STEM BIO
Industry:
Biotechnology Health Care Product Research
Founded:
2019-01-01
Address:
Sunchang, Cholla-bukto, South Korea
Country:
South Korea
Website Url:
http://www.stembio.co.kr
Status:
Active
Contact:
+82 031 711 5507
Email Addresses:
[email protected]
Total Funding:
1.35 B KRW
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Axonova
Axonova is a developer of pharmaceutical and nutraceutical drugs.
Doublle Bioproduct
Doublle Bioproduct focuses on the research and development of anti-tumor drugs.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Japan Proteomics
Japan Proteomics provides research and development of technology for protein identification.
Oregon Therapeutics
Oregon Therapeutics is a developer of new anti-cancer drugs.
SinoMab Bioscience
SinoMab Bioscience is dedicated to the research, development, manufacturing and commercialization of therapeutics.
T-Maximum
T-Maximum develops CAR-T cell therapies for the treatment of brain tumors.
Tyercan
Tyercan focuses on the research and development of innovative targeted anti-cancer and immunosuppressive drugs.
Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products.
Investors List
Korea University Holdings
Korea University Holdings investment in Seed Round - Stem Bio
Square Ventures
Square Ventures investment in Angel Round - Stem Bio
Technology Guarantee Fund
Technology Guarantee Fund investment in Seed Round - Stem Bio
Ipmagna
Ipmagna investment in Seed Round - Stem Bio
More informations about "Stem Bio"
Stembio Cell and Tissue Technologies Inc. - LinkedIn
Stembio Cell and Tissue Technologies Inc. Biotechnology Research Gebze, Kocaeli 6,405 followers Our purpose is to build a leading, focused ATMPs company powered by advanced therapy products and ...See details»
Stembio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Stembio. Use the PitchBook Platform to explore the full profile.See details»
Stembio Cell and Tissue Technologies - PitchBook
Information on acquisition, funding, investors, and executives for Stembio Cell and Tissue Technologies. Use the PitchBook Platform to explore the full profile.See details»
๋ํ์ ์ธ์ฌ๋ง - About us - ๋ค์ด๋ฒ ๋ธ๋ก๊ทธ
May 20, 2024 2020๋ ์ ์ค๋ฆฝ๋ STEMBIO๋ ์๋ช ๊ณตํ ๋ถ์ผ์ ํ์ ๊ณผ ๋ฐ์ ์ ํตํด ์ธ๋ฅ์ ๊ฑด๊ฐ๊ณผ ๋ณต์ง๋ฅผ ํฅ์์ํค๊ธฐ ์ํด ๋ ธ๋ ฅํด์์ต๋๋ค. ์ง๋ ๋ช ๋ ๋์, ์ฐ๋ฆฌ๋ ์ ์ ์ ์น๋ฃ์ ๋ง์ถคํ ์์ฝํ ๊ฐ๋ฐ์ ํตํด ๋ง์ ์ฑ๊ณผ๋ฅผ ์ด๋ฃจ์ด๋๊ณ , ์์ผ๋ก๋ โฆSee details»
Stembio Cell Technologies - Crunchbase Company โฆ
Stembio Cell Technologies is a biotech company that offers stem cell and tissue technology to conduct gene editing and COVID-19 research.See details»
Stembio - 2025 Company Profile & Competitors - Tracxn
Apr 7, 2025 Stembio - About the company Stembio is an acquired company, founded in 2020. It operates as a Provider of human cell and tissue processing, storage, and clinical supply. The โฆSee details»
Stem Bio Co.,Ltd. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Stem Bio Co.,Ltd. of Asan, Chungnam. Get the latest business insights from Dun & Bradstreet.See details»
Stem Bio - Products, Competitors, Financials, Employees, โฆ
About Stem Bio Stem Bio operates within the biotechnology sector, providing services related to the analysis and treatment of cancer. The company utilizes genetic research and stem cell โฆSee details»
Stem Bio Co., Ltd.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Stem Bio Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
์ฃผ์ํ์ฌ ์คํ ๋ฐ์ด์ค ์ฑ์ฉ|์๋ช ๋ฐ ์์ฐ๊ณผํ ๊ด๋ จ์ง|์์์ข ๋ฐ โฆ
์์์ข ๋ฐ ์ค๊ธฐ์ธํฌ ๊ด๋ จ ํญ์ฒดํญ์์ ๊ฐ๋ฐ ์์ฌ๊ธ ์ฐ๊ตฌ์ ๋ชจ์ง ๊ณตํต ์๊ฒฉ ์๊ฑด - ํ๋ ฅ : ์์ฌ ์กธ์ (์กธ์ ์์ ์ ์ง์ ๊ฐ๋ฅ) - ๊ฒฝ๋ ฅ : ๋ฌด๊ด (์ ์ ์ง์ ๊ฐ๋ฅ) (์ฃผ์, ๋๋ฆฌ๊ธ) ์ฐ๊ตฌ ๋ถ์ผ - ์์์ข ๋ฐ โฆSee details»
STEMBIO - Company Information, Competitors, News & FAQs
Find useful insights on STEMBIO's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at STEMBIO.See details»
Global Stem Cells Group Partners with StemBio to Advance โฆ
Miami, Floridaโ Global Stem Cells Group, a leader in regenerative medicine, is thrilled to announce a strategic partnership with StemBio, a renowned leader in the regenerative โฆSee details»
๊ธ๋ก๋ฒ ์ธํฌ์น๋ฃ์ ์ ๋๊ธฐ์ -๊ฐ์คํ ๋ฐ์ด์คํ
Noble Life & Healthy - Ageing ๋ชจ๋๊ฐ ๊ฑด๊ฐํ๊ณ ํ๋ณตํ๊ฒ ์ด์๊ฐ๋ ์ธ์์ ๋ง๋ค์ด๊ฐ๊ฒ ์ต๋๋ค. ์ค๊ธฐ์ธํฌ ์น๋ฃ์ ์ฌ์ ๊ฐ์คํ ๋ฐ์ด์คํ ์ ํฌ๊ท·๋์น์ฑ ์งํ์ ํ๊ฒ์ผ๋ก ํ๋ ์ค๊ธฐ์ธํฌ ์น๋ฃ์ ๋ฅผ โฆSee details»
Stem Bio - Funding, Financials, Valuation & Investors - Crunchbase
Stem Bio is a developer of stem cell therapy and anti-cancer drugs.See details»
Kordon Kanฤฑ ve Kordon Dokusu Bankacฤฑlฤฑฤฤฑ | Stemcord.com.tr
Stembio/Stemcord yeni nesil biyoteknoloji üssü olarak Türkiyeโde ilk ve tek hibrit hücre ve doku merkezi olma özelliฤine sahiptir. Üstün teknolojisiyle insan kaynaklฤฑ hücreleri ve dokularฤฑ iลler, โฆSee details»
KSTEMBIO
The possibility of stem cells Business on cell therapy and procedures using stem cellsSee details»
Koc Holding acquires Stembio Cell Technologies - 2024-09-20 ...
Stembio Cell Technologies Stembio Cell Technologies is a biotech company that offers stem cell and tissue technology to conduct gene editing and COVID-19 research.See details»
The First and Only Hybrid Cell and Tissue Center in Turkey: Tissue ...
Jul 29, 2022 Biotechnology center Stembio Cord Blood Cell and Tissue Center was established to support the introduction of modern health technologies that are developing at the cellular โฆSee details»
Stem Bio
Stem Bio specializes in the production of quality, data driven analytics and solutions. Including, but not limited too, big data management and analysis, data processing, systems automation โฆSee details»
DNA organization offers clues for advancing stem cell therapy
Apr 16, 2025 DNA organization offers clues for advancing stem cell therapy UC Riverside-led study could help advance treatments for injuries, aging, and diseasesSee details»